JOURNAL OF NEUROTRAUMA, 2015 · DOI: 10.1089/neu.2014.3703 · Published: August 1, 2015
After a spinal cord injury, scar tissue that contains glial and fibrotic components forms at the injury site. While the glial scar has received more attention, the fibrotic scar is made up of fibroblasts and a dense extracellular matrix (ECM). The fibrotic scar can inhibit axon growth, so understanding how it's formed may offer new insights into spinal cord injury pathology. Fibronectin, an extracellular matrix protein, is highly present in the fibrotic scar. After SCI, excess deposition of fibronectin comes from multiple sources, such as reactive astrocytes, macrophages, and fibroblasts. Fibronectin needs to polymerize into a fibrillar network to be a functional matrix, initiated by binding to cellular integrin receptors. However, whether or how this fibronectin matrix assembly occurs after SCI is not known. This study shows that fibronectin is assembled into a matrix to form the fibrotic scar, a process likely mediated by the fibronectin receptor integrin a5b1, which is primarily expressed by activated macrophages/microglia. The study also demonstrates the presence of fibrotic markers in a rat contusion model, highlighting the clinical relevance of the fibrotic scar.
Understanding fibronectin matrix assembly after SCI may allow targeting of multiple inhibitory molecules in the fibrotic scar to promote axon regeneration.
The presence of fibrotic scarring in rat SCI models suggests relevance to human SCI pathology, warranting further investigation.
Identifying fibroblasts as the primary source of fibronectin and macrophages/microglia expressing integrin a5b1 suggests cell-specific therapeutic targets.